X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (493) 493
Publication (62) 62
Book Chapter (9) 9
Conference Proceeding (2) 2
Book Review (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (349) 349
transplantation (298) 298
index medicus (272) 272
hematology (266) 266
male (220) 220
female (216) 216
immunology (202) 202
adult (166) 166
bone-marrow-transplantation (149) 149
oncology (138) 138
adolescent (130) 130
middle aged (127) 127
transplantation, homologous (112) 112
versus-host-disease (112) 112
child (108) 108
stem cells (106) 106
hematopoietic stem cells (104) 104
animals (100) 100
leukemia (98) 98
treatment outcome (95) 95
histocompatibility testing (87) 87
hematopoietic stem cell transplantation (84) 84
hematopoietic stem cell transplantation - methods (82) 82
graft vs host disease - prevention & control (78) 78
stem-cell transplantation (76) 76
tissue donors (76) 76
child, preschool (74) 74
transplantation conditioning - methods (64) 64
histocompatibility (63) 63
young adult (61) 61
acute myeloid-leukemia (59) 59
bone marrow (58) 58
hematopoietic stem cell transplantation - adverse effects (58) 58
graft survival (56) 56
unrelated donors (56) 56
bone marrow transplantation (55) 55
haplotypes (53) 53
hematology, oncology and palliative medicine (51) 51
leukemia - therapy (51) 51
mismatched hla (51) 51
disease-free survival (50) 50
hla antigens - immunology (50) 50
t cells (49) 49
aged (48) 48
analysis (47) 47
article (47) 47
hla-mismatched/haploidentical blood (47) 47
haploidentical (44) 44
recurrence (44) 44
research (44) 44
acute disease (43) 43
graft vs host disease - immunology (43) 43
hematologic malignancies (43) 43
mismatched renal-transplantation (43) 43
stem cell transplantation (43) 43
tolerance (43) 43
acute lymphoblastic-leukemia (42) 42
care and treatment (42) 42
retrospective studies (42) 42
risk factors (42) 42
surgery (42) 42
relapse (41) 41
transplantation conditioning (41) 41
graft vs host disease - etiology (40) 40
health aspects (40) 40
t-cells (40) 40
regulatory t-cells (39) 39
survival analysis (39) 39
acute-leukemia (38) 38
bone-marrow transplantation (38) 38
children (38) 38
engraftment (38) 38
infant (38) 38
mice (36) 36
survival rate (36) 36
chimerism (35) 35
t-lymphocytes - immunology (35) 35
umbilical-cord blood (35) 35
donors (34) 34
histocompatibility antigens (34) 34
hla antigens - genetics (33) 33
hla histocompatibility antigens (33) 33
cancer (32) 32
graft-versus-host disease (32) 32
high-risk (32) 32
lymphocyte depletion (32) 32
mortality (32) 32
pediatrics (32) 32
survival (32) 32
transplantation tolerance (32) 32
allografts (31) 31
hematologic neoplasms - therapy (31) 31
lymphocytes (31) 31
immune reconstitution (30) 30
versus-host disease (29) 29
antithymocyte globulin (28) 28
graft (28) 28
gvhd (28) 28
leukemia, myeloid, acute - therapy (28) 28
recipients (28) 28
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Transplantation, ISSN 1600-6135, 08/2017, Volume 17, Issue 8, pp. 2020 - 2032
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 08/2017, Volume 189, Issue 2, pp. 190 - 196
Journal Article
Journal Article
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 04/2018, Volume 141, Issue 4, pp. 1417 - 1426.e1
Allogeneic hematopoietic stem cell transplantation (HSCT) is used as a therapeutic approach for primary immunodeficiencies (PIDs). The best outcomes have been... 
hematopoietic stem cell transplantation | CD3+ T-cell receptor αβ+ cell depletion | haploidentical | mismatched unrelated | Primary immunodeficiency | cell depletion | CD3 | T-cell receptor αβ | Busulfan - analogs & derivatives | Immunologic Deficiency Syndromes - therapy | Humans | Antilymphocyte Serum - immunology | Child, Preschool | Hematopoietic Stem Cell Transplantation | Infant | Male | Receptors, Antigen, T-Cell, alpha-beta - immunology | Thiotepa - immunology | Vidarabine - analogs & derivatives | Graft vs Host Disease - immunology | CD3 Complex - immunology | Vidarabine - immunology | Female | Graft vs Host Disease - prevention & control | Retrospective Studies | Transplantation Conditioning - methods | Busulfan - immunology | Immunologic Deficiency Syndromes - immunology | Child | Alemtuzumab - immunology | Antigens, CD19 - immunology | Graft-versus-host reaction | Transplants & implants | Liver | Prophylaxis | Stem cell transplantation | Transplantation | Lymphocytes T | Infections | Treosulfan | Drug resistance | Grafting | Hematopoietic stem cells | T-cell receptor | Demographics | Lymphocytes | Children | Busulfan | Conditioning | Cytomegalovirus | Immunoglobulins | CD19 antigen | Neutrophils | Health risks | Immunodeficiency | Transplants | CD3 antigen | T cell receptors | Patients | Survival | Hemopoiesis | Graft rejection | Rejection | Fludarabine | Grafts | Depletion | Globulins | Thymocytes | Adenoviruses | Stem cells | Monoclonal antibodies | Histocompatibility antigen HLA | Methods | Viral infections
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 08/2018, Volume 11, Issue 1, pp. 110 - 10
Background: Thiotepa-busulfan-fludarabine (TBF) is a widely used conditioning regimen in single umbilical cord blood transplantation (SUCBT). More recently, it... 
Stem cell transplantation | Haploidentical stem cell transplantation | Acute myeloid leukemia | Conditioning regimens | Thiotepa-busulfan-fludarabine | Umbilical cord blood transplantation | HLA-MISMATCHED/HAPLOIDENTICAL BLOOD | BONE-MARROW-TRANSPLANTATION | UNRELATED DONORS | IDENTICAL-SIBLING TRANSPLANT | VERSUS-HOST-DISEASE | REDUCED-INTENSITY | ONCOLOGY | HIGH-RISK | ACUTE LYMPHOBLASTIC-LEUKEMIA | STEM-CELL TRANSPLANTATION | HEMATOLOGY | HEMATOLOGIC MALIGNANCIES | Thiotepa - therapeutic use | Busulfan - pharmacology | Busulfan - therapeutic use | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Male | Survival Rate | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Transplantation, Haploidentical - mortality | Transplantation Conditioning - mortality | Young Adult | Cord Blood Stem Cell Transplantation - methods | Vidarabine - pharmacology | Transplantation, Haploidentical - methods | Adult | Female | Aged | Retrospective Studies | Thiotepa - pharmacology | Cord Blood Stem Cell Transplantation - mortality | Transplantation Conditioning - methods | Leukemia, Myeloid, Acute - therapy | Fetal blood | Care and treatment | Leukemia | Physiological aspects | Transplantation | Research | Methods | Antigens | Graft-versus-host reaction | Statistical analysis | Transplants & implants | Disease | Hematology | Myeloid leukemia | Lymphocytes T | Multivariate analysis | Patients | Rejection | Grafts | Fludarabine | Cord blood | Lymphocytes | Stem cells | Bone marrow | Remission | Umbilical cord | Busulfan | Life Sciences
Journal Article